NCT02929550View on ClinicalTrials.gov

Impact of Guidelines on Cardiovascular and Economic Outcomes With Focus on Lipid Lowering Drugs

CompletedOBSERVATIONAL
Enrollment

5,304

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

April 30, 2016

Conditions
Acute Myocardial Infarction
Interventions
OTHER

Well-controlled

Both groups got treatment but well-controlled reached target of LDL-C\<1.8 mmol/l

All Listed Sponsors
collaborator

Uppsala University

OTHER

lead

Karolinska Institutet

OTHER

NCT02929550 - Impact of Guidelines on Cardiovascular and Economic Outcomes With Focus on Lipid Lowering Drugs | Biotech Hunter | Biotech Hunter